FRANCIOTTA, DIEGO
 Distribuzione geografica
Continente #
NA - Nord America 746
EU - Europa 435
AS - Asia 201
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 1.384
Nazione #
US - Stati Uniti d'America 745
IE - Irlanda 219
CN - Cina 181
FI - Finlandia 72
IT - Italia 49
DE - Germania 32
UA - Ucraina 21
BE - Belgio 14
IN - India 10
CZ - Repubblica Ceca 8
GB - Regno Unito 7
FR - Francia 6
SG - Singapore 5
JP - Giappone 4
SE - Svezia 3
AT - Austria 1
AU - Australia 1
CA - Canada 1
CW - ???statistics.table.value.countryCode.CW??? 1
LU - Lussemburgo 1
MD - Moldavia 1
RO - Romania 1
TR - Turchia 1
Totale 1.384
Città #
Chandler 219
Dublin 219
Ashburn 83
Helsinki 52
Jacksonville 47
Nanjing 39
Lawrence 31
Princeton 31
Beijing 28
Boardman 27
Medford 26
Wilmington 24
Shanghai 22
Ann Arbor 20
Shenyang 20
Nanchang 19
New York 19
Brussels 14
Hebei 13
Jiaxing 12
Changsha 10
Pune 10
Los Angeles 9
Brno 6
Fairfield 6
Milan 6
Rome 6
Woodbridge 6
Tianjin 5
Hangzhou 4
Piscataway 4
Tokyo 4
Berlin 3
Cambridge 3
Dearborn 3
Jinan 3
Pavia 3
Seattle 3
Seveso 3
Washington 3
Florence 2
Munich 2
Naples 2
Norwalk 2
Olomouc 2
Osio Sotto 2
Palermo 2
San Francisco 2
Singapore 2
Torino 2
Treviso 2
Verona 2
Auburn Hills 1
Changchun 1
Chisinau 1
Fayetteville 1
Fuzhou 1
Guangzhou 1
Hanover 1
Hefei 1
Luxembourg 1
Magenta 1
Melbourne 1
Ningbo 1
Novara 1
Orange 1
Redwood City 1
Reghin 1
Rockville 1
Scuola 1
Tappahannock 1
Toronto 1
Willemstad 1
Totale 1.110
Nome #
Inverse association between multiple sclerosis and respiratory allergic diseases 70
Combined central and peripheral demyelination: Clinical features, diagnostic findings, and treatment 70
Late post-transplant anti-aquaporin-4 Ab-positive optic neuritis in a patient with AML 64
Predictors of outcome in a large retrospective cohort of patients with transverse myelitis 62
Meningeal melanomatosis: a challenge for timely diagnosis. 58
Correlation of frontal atrophy and CSF tau levels with neuropsychiatric symptoms in patients with cognitive impairment: a memory clinic experience 58
Cell-cycle inhibition by Helicobacter pylori L-asparaginase. 56
Gender difference and autoimmune disease: a study of polymorphic MHC genomic markers in myasthenia gravis (MG) 53
Measurement of skeletal muscle mass in Duchenne muscular disease: usefulness of 24-hour creatinine excretion 52
Devic's neuromyelitis optica: long-term follow-up and serial CSF findings in two cases. 52
Genetic basis for idiosyncratic reactions to antiepileptic drugs. 52
Lack of antibodies to neuropil antigens in idiopathic REM sleep behavior disorder 49
Diagnostics of anti-MAG antibody polyneuropathy 47
Immunohistochemical characterization of a new atypic antibody in a paraneoplastic neurological syndromes. 44
COVID-19 and Guillain–Barré Syndrome: A Case Report and Review of Literature 44
Air pollution as a contributor to the inflammatory activity of multiple sclerosis 43
Conventional brain MRI features distinguishing limbic encephalitis from mesial temporal glioma 42
Diagnostics of dysimmune peripheral neuropathies 42
Antibodies to neuronal surface antigens in patients with a clinical diagnosis of neurodegenerative disorder 42
Antibodies to neurofascin, contactin-1, and contactin-associated protein 1 in CIDP: Clinical relevance of IgG isotype 41
Absence of pathogenic mutations in CD59 in chronic inflammatory demyelinating polyradiculoneuropathy 38
Cranial nerve palsies in patients with hematological malignancies: a case series 38
Polymorphic markers in MHC class II/III region: a study on Italian patients with myastenia gravis 37
Remarkable Rituximab Response on Tremor Related to Acute-Onset Chronic Inflammatory Demyelinating Polyradiculoneuropathy in an Antineurofascin155 Immunoglobulin G4–Seropositive Patient 36
Primary central nervous system lymphoma mimicking autoimmune encephalitis: the role of autoantibody testing 36
Guillain-Barré syndrome associated with SARS-CoV-2 35
Ceftazidime/avibactam neurotoxicity in an adult patient with normal renal function 34
Role of Cerebrospinal Fluid Biomarkers and (18)F-florbetapir PET Imaging in the Diagnosis of Primary Progressive Aphasia: A Retrospective Analysis 32
Correction: Absence of pathogenic mutations in CD59 in chronic inflammatory demyelinating polyradiculoneuropathy (PLoS ONE (2019) 14: 2 (e0212647) DOI: 10.1371/journal.pone.0212647) 32
COVID-19 in patients with Myasthenia Gravis: epidemiology and disease course 32
Ambroxol as a disease-modifying treatment to reduce the risk of cognitive impairment in GBA-associated Parkinson's disease: a multicentre, randomised, double-blind, placebo-controlled, phase II trial. The AMBITIOUS study protocol 22
Thyroid function in the subacute phase of traumatic brain injury: a potential predictor of post-traumatic neurological and functional outcomes 18
Hodgkin Lymphoma With Diplopia and Nystagmus: A Paraneoplastic Cerebellar Degeneration With Ectopic Expression of DNER Antigen on Reed-Sternberg Cells 1
Totale 1.432
Categoria #
all - tutte 6.172
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.172


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020176 53 70 0 3 0 6 4 4 1 16 19 0
2020/202194 5 5 1 4 9 8 2 32 7 11 5 5
2021/2022148 5 1 3 2 5 4 3 7 12 3 21 82
2022/2023614 56 56 4 58 41 60 0 27 270 10 24 8
2023/2024314 33 45 3 20 14 77 12 36 0 14 14 46
Totale 1.432